XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-based Compensation and Other Stock Plans - (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted-Average Assumptions of Fair Value Granted Using Black-Scholes Valuation Model
The following weighted-average assumptions were used in calculating the fair value of stock options granted during the nine month periods ended September 30, 2023, and October 1, 2022, using the Black-Scholes valuation model:

Nine Months Ended
September 30, 2023October 1, 2022
Expected term of option (in years)
4.895.14
Expected volatility factor23.99%22.61%
Expected dividend yield2.60%2.68%
Risk-free interest rate3.99%2.00%
Schedule of Stock Option Activity
Below is a summary of stock option activity as of and for the nine months ended September 30, 2023:

Shares
(in thousands)
Exercise
Price Per
Share*
Remaining
Contractual
Term*
(in years)
Aggregate
Intrinsic
Value
(in millions)
Outstanding at December 31, 20222,349 $163.07 
Granted241 249.28 
Exercised(524)150.06 
Forfeited or expired(22)218.12 
Outstanding at September 30, 20232,044 175.99 5.4$161.7 
Exercisable at September 30, 20231,535 159.80 4.4146.3 
*Weighted-average
Schedule of Changes in Non-Vested Performance Awards
Changes to the company’s non-vested PSUs during the nine months ended September 30, 2023, are as follows:
Shares
(in thousands)
Fair Value
Price per
Share*
Non-vested PSUs at December 31, 2022199 $196.51 
Granted58 249.26 
Performance assumption change **30 211.67 
Vested— — 
Cancellations and other(4)215.56 
Non-vested PSUs at September 30, 2023283 208.71 
*Weighted-average
**Reflects the number of PSUs above target levels based on performance metrics.
Schedule of Non-vested Restricted Stock Units Activity
Changes to the company’s non-vested RSUs during the nine months ended September 30, 2023, are as follows:
Shares
(in thousands)
Fair Value
Price per
Share*
Non-vested RSUs at December 31, 202258 $200.16 
Granted26 249.26 
Vested(1)196.44 
Cancellations and other(2)215.96 
Non-vested RSUs at September 30, 202381 215.66 
*Weighted-average
Schedule of Weighted-Average Assumptions of Fair Value Granted Using Black-Scholes Valuation Model
The following weighted-average assumptions were used in calculating the fair value of stock-settled SARs granted during the nine months ended September 30, 2023, and October 1, 2022, using the Black-Scholes valuation model:
 Nine Months Ended
 September 30, 2023October 1,
2022
Expected term of stock-settled SARs (in years)
4.084.02
Expected volatility factor24.68%23.09%
Expected dividend yield2.60%2.68%
Risk-free interest rate3.87%1.96%
The following weighted-average assumptions were used in calculating the fair value of cash-settled SARs granted during the nine months ended September 30, 2023, and October 1, 2022, using the Black-Scholes valuation model:
Nine Months Ended
September 30, 2023October 1,
2022
Expected term of cash-settled SARs (in years)
3.543.37
Expected volatility factor23.97%23.78%
Expected dividend yield2.54%2.82%
Risk-free interest rate4.80%4.25%
Schedule of Changes in SARs
Below is a summary of stock-settled SARs as of and for the nine months ended September 30, 2023:
Stock-settled
SARs
(in thousands)
Exercise
Price Per
Share*
Remaining
Contractual
Term*
(in years)
Aggregate
Intrinsic
Value
(in millions)
Outstanding at December 31, 2022385 $170.11 
Granted62 249.26 
Exercised(47)152.40 
Forfeited or expired(73)161.76 
Outstanding at September 30, 2023327 189.52 6.7$21.4 
Exercisable at September 30, 2023195 165.35 5.417.5 
*Weighted-average
Changes to the company’s non-vested cash-settled SARs during the nine months ended September 30, 2023, are as follows:
Cash-settled
SARs
(in thousands)
Fair Value
Price per
Share*
Non-vested cash-settled SARs at December 31, 2022$53.24 
Granted51.86 
Vested(1)79.48 
Non-vested cash-settled SARs at September 30, 202359.29 
*Weighted-average